Similarly, we have previously shown Cyr61 activation in the pancreatic cancer xenograft [37], in the human pancreatic cancer cell lines [38], and in the pancreatic carcinoma [39]. This evidence concerns the gene CCN1 and exocrine pancreatic carcinoma.